Andrew L. Tussing
COO & Corporate Secretary
Mr. Tussing has been involved in the founding and building of businesses throughout most of his career. A co-founder of the Company, he raised the needed capital to launch Vaccinogen. Mr. Tussing leads the Company’s operations as well as the commercialization of OncoVAX®. Previously, Mr. Tussing was active in investment banking activities at 1st BridgeHouse Securities and as Managing Director of Growth5 – a venture capital marketing strategy firm.
Prior to that, Mr. Tussing was a co-founder of Milestone International Asset Management which developed hedge-fund-related solutions for financial advisors. He also served in senior roles at Pershing, a division of the Bank of New York, and at Deutsche Bank’s Alex. Brown division where he was Director of Strategic Development, Marketing & Sales for its Correspondent Services business.
Early in his career, Mr. Tussing had the rare opportunity to help develop a completely new and autonomous business within America’s oldest investment bank - Alex. Brown Incorporated – and was key to growing it to over $60 million in revenues.